Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Alembic Pharmaceuticals Limited (NSE: APLLTD), ISIN INE901L01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APLLTD last traded at ₹1020.55 (+5.74%), with a 52-week range of ₹635.80 to ₹1055.70 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 69.87%, FIIs 4.55%, DIIs 15.44%, mutual funds 8.50%.
EquiSense Score (ECS): 70/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.